Ani (Ani)
Lithobid Tablet, Film Coated, Extended Release
Product Images NDC 62559-280
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lithobid (NDC 62559-280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Image 01)
Label for LITHOBID (lithium carbonate USP) Extended-Release Tablets, 300 mg strength, oral dosage form. The label indicates 100 tablets per container, manufactured by ANI Pharmaceuticals, Inc. of Baudette, MN. It includes storage instructions, warnings, and dispensing instructions, with a barcode and NDC number 62559-280-01.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
